Tectonic Therapeutic | AVRO - Loan Capital


Tectonic Therapeutic reported $100K in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Akebia Therapeutics USD 48.25M 609K Dec/2025
Alnylam Pharmaceuticals USD 2.48B 1.44B Dec/2025
Celltrion KRW 63.29B 4.01B Sep/2025
Cspc Pharmaceutical CNY 158.75M 102.62M Jun/2025
Deva Holding AS TRY 559.97M 44.39M Sep/2023
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd INR 20M 0 Mar/2025
Gilead Sciences USD 22.14B 5M Sep/2025
Ionis Pharmaceuticals USD 1.9B 1.87B Dec/2025
Kangmei Pharma CNY 78.45M 5.8M Sep/2025
Karyopharm Therapeutics USD -0.93 0.67 Dec/2024
Knight Therapeutics CAD 84.7M 2.17M Sep/2025
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
MacroGenics USD 70.26M 4K Sep/2025
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 1.5M 167K Dec/2025
Organigram Holdings CAD 76.4M 23.6M Sep/2025
Ovoca Bio EUR 0 0 Jun/2021
Pfizer USD 57.41B 93M Sep/2025
Pharma Mar EUR 36.68M 1.07M Dec/2025
Qiagen NV USD 1.65B 15.23M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sangamo BioSciences USD 0 0 Jun/2022
Sanofi EUR 15.72B 2.45B Dec/2025
Sarepta Therapeutics USD 828.97M 206.17M Dec/2025
Sartorius EUR 3.41B 682.5M Sep/2025
Sino Biopharmaceutical CNY 3.08B 1B Jun/2025
Takeda JPY 4.27T 81.29B Dec/2025
Tilray USD 279.22M 18.87M Mar/2025
Zz Pientze Pharmaceu CNY 186.56M 9.75M Sep/2025